Clinical Trial Update: Naldebain for Pain Management After Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Naldebain in pain management after knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthropathy of Knee Joint

Drugs mentioned

• Naldebain (dinalbuphine ester)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Arthropathy of Knee Joint | Phase 4 | Status: COMPLETED